Capturing B type acute lymphoblastic leukemia cells using two types of antibodies

Abstract

One way to monitor minimal residual disease (MRD) is to screen cells for multiple surface markers using flow cytometry. In order to develop an alternative microfluidic based method, isolation of B type acute lymphoblastic cells using two types of antibodies should be investigated. The immunomagnetic beads coated with various antibodies are used to capture the B type acute lymphoblastic cells. Single beads, two types of beads and surface immobilized antibody were used to measure the capture efficiency. Both micro and nanosize immunomagnetic beads can be used to capture B type acute lymphoblastic cells with a minimum efficiency of 94% and maximum efficiency of 98%. Development of a microfluidic based biochip incorporating immunomagnetic beads and surface immobilized antibodies for monitoring MRD can be an alternative to current cost and time inefficient laboratory methods. © 2018 American Institute of Chemical Engineers Biotechnol. Prog., 35: e2737, 2019

The influence of RANKL/osteoprotegerin on the prognosis of childhood acute lymphoblastic leukemia

“…In order to provide this, different methods are being investigated for minimal residual disease monitoring. 5,6 Owing to the multiagent chemotherapy protocols, central nervous system-directed regimens, and better management of side effects, pediatric ALL patients have achieved a 5-year overall survival rate of 90%. 7 Despite this excellent survival rate, long-term morbidities constitute the most important challenge.…”

Magnetic Separation of Micro Beads and Cells on a Paper-Based Lateral Flow System

“…Magnetic particles and external magnetic fields were also incorporated with LFBs for separation and preconcentration of target proteins [16]. Besides the isolation of target biomolecules [17], magnetic particles have also other advantages which make them attractive for biosensors such as signal amplification [18,19], sensitivity enhancement [20] and visual labeling [21,22].…”